SCHEMBL25539109

SCHEMBL25539109

CC1(C)c2cccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5cc(-c6ccccc6)ccc5-c5ccccc5)n4)c4ccccc34)c2-c2ccc3ccccc3c21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ENPP3 O14638 2/20 0.32
ACACA Q13085 1/20 0.32
ENPP1 P22413 1/20 0.32
CA12 O43570 3/20 0.32
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
SLC6A9 P48067 1/20 0.32
PSD A5PKW4 1/20 0.31
PDK2 Q15119 3/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PIM1 P11309 1/20 0.31
RARB P10826 1/20 0.31
RARG P13631 1/20 0.31
RXRA P19793 1/20 0.31
CYP1A1 P04798 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539111 0.97 KDM4E (0.33) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25540414 0.96 ALDH1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25539100 0.96 ALDH1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25539115 0.95 CYP1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25540241 0.94 MAPT (0.35) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25539080 0.94 MAPT (0.35) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25540238 0.94 CYP1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25539095 0.94 CYP1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25540410 0.94 CYP1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3
SCHEMBL25539077 0.94 CYP1A1 (0.34) KDM4EALDH1A1MAPTHPGDENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM KDM4E 1565/4885ALDH1A1 254/4885MAPT 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.